Structural and functional alterations of alpha satellite DNA in human hepatocellular carcinoma
Structural and functional alterations of alpha satellite DNA in human hepatocellular carcinoma
批准号:
10670458
负责人:
OGATA Norio
金额:
$2.37万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Molecular mechanisms of the development of human hepatocellular carcinoma have not been elucidated. We previously found that genomic DNA of hepatitis B virus (HBV) was integrated into alpha satellite DNA located in the centromeric region of chromosomes in human hepatocellular carcinoma cells. We also found that the primary structure of the alpha satellite DNA underwent rearrangement associated with the HBV DNA integration. Because such DNA alterations were not identified in hepatocytes, we considered that the rearrangement of the alpha satellite DNA might have been involved in the development of hepatocellular carcinoma. We analyzed in detail the primary structure of the rearranged alpha satellite DNA. The results showed that the DNA underwent an inverted duplication associated with the HBV integration. To examine possible functions of the rearranged alpha satellite DNA for the development of hepatocellular carcinoma, we tested cell-transforming activity of the cloned, rearranged alpha … More satellite DNA (pYSC) using human diploid cell lines. Up to the present, we have failed in having convincing evidence that the rearranged alpha satellite DNA has the cell-transforming activity.One goal of antiviral treatment against chronic hepatitis B is to prevent the development of hepatocellular carcinoma. It has been known that HBV genomes are integrated into chromosomes of hepatocytes in chronic hepatitis B. To investigate whether genotypic mutations of HBV would occur during antiviral treatment, whether integration of such mutant viruses may be integrated into hepatocytes, and whether integration of such variant viruses may differ from that of wild-type HBV for the contribution to the development of hepatocellular carcinoma, we examined the occurrence of genotypic mutations of HBV while on lamivudine treatment. The results demonstrated that the mutations occurred in some of patients. Currently, we are examining the integration of such mutant HBV in the liver tissue obtained through needle biopsy. Less
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Norio Ogata, et al.: "Novel patterns of amino acid mutations in the hepatitis B virus polymerase. in association with the virus resistance to lamivudine."Journal of Medical Virology. 59.(3). 270-276 (1999)
Norio Ogata 等人:“乙型肝炎病毒聚合酶中氨基酸突变的新模式。与病毒对拉米夫定的耐药性相关。”医学病毒学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
小方則夫: "肝疾患研究の新しい展開.第III巻.(分担執筆:ウイルス性肝炎における肝発癌機構)"メディカル レビュー社(分担分.211-226). 248 (1998)
Norio Ogata:“肝脏疾病研究的新进展。第三卷。(撰稿人:病毒性肝炎中肝癌发生的机制)”Medical Review Co., Ltd.(撰稿人:211-226)248(1998)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
海外基金